3-O-ethyl 5-O-[[1-(2-phenylethyl)triazol-4-yl]methyl] 4-[3-(4-bromophenyl)-5-methyl-1,2-oxazol-4-yl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

InChIKey	`KFBQDAJEXXORSH-UHFFFAOYSA-N`
Compound Name	3-O-ethyl 5-O-[[1-(2-phenylethyl)triazol-4-yl]methyl] 4-[3-(4-bromophenyl)-5-methyl-1,2-oxazol-4-yl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
Canonical SMILES	`CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCc2cn(CCc3ccccc3)nn2)C1c1c(-c2ccc(Br)cc2)noc1C`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Homologous
Avg pChEMBL	6.9
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O60840	CACNA1F	Homo sapiens	Human	PF08763 PF16885 PF16905 PF00520	6.9	IC50	ChEMBL
Q01668	CACNA1D	Homo sapiens	Human	PF08763 PF16885 PF16905 PF00520	6.9	IC50	ChEMBL
Q13698	CACNA1S	Homo sapiens	Human	PF08763 PF16905 PF00520	6.9	IC50	ChEMBL
Q13936	CACNA1C	Homo sapiens	Human	PF08763 PF16885 PF16905 PF00520	6.9	IC50	ChEMBL